Small Animal Imaging (In-Vivo) Market 2024 - By Size, Trends, Opportunities And Forecast To 2033

The small animal imaging (in-vivo) market size has grown rapidly in recent years. It will grow from $2.59 billion in 2023 to $2.91 billion in 2024 at a compound annual growth rate (CAGR) of 12.6%. The growth in the historic period can be attributed to preclinical research and drug development, expansion of pharmaceutical and biotechnology sectors, growth in translational research, disease modeling and pathophysiology studies, academic and government funding for research..

The small animal imaging (in-vivo) market size is expected to see rapid growth in the next few years. It will grow to $4.55 billion in 2028 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to development of novel imaging probes and tracers, expansion of preclinical cros (contract research organizations), integration of ai in image analysis, advanced multimodal imaging systems, 3d and high-resolution imaging for small animals, rise in research for rare and orphan diseases.. Major trends in the forecast period include molecular and functional imaging in small animals, longitudinal and real-time in-vivo imaging, hybrid imaging modalities for multimodal information, imaging of crispr-edited animals for genetics research, ai-driven phenotyping and biomarker discovery, imaging for neurodegenerative diseases and neuroscience..

Market Overview -
Small animal imaging (in vivo) refers to the advanced imaging techniques for monitoring cellular activity, pharmacological effects that have been developed, and disease progression in live animals. Small animal imaging (in vivo) is used to observe, define, and quantify normal and pathologic processes in living animal organs and tissues non-invasively.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=7303&type=smp

Elevated Healthcare Expenditure Fueling Growth In The Small Animal Imaging (In-Vivo) Market
Growing expenditure in the healthcare sector is expected to propel the growth of the small animal imaging (in vivo) market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure and increasing healthcare awareness encourage the concept of self-care management, where PET equipment is used in techniques such as small animal imaging. For instance, in May 2023, the Office for National Statistics, a UK-based statistics authority, reported that healthcare spending in the UK increased by 9.4% in nominal terms and 9.7% in real terms. UK total healthcare expenditure in 2021 was $367.25 billion (£280.7 billion), and pharmaceutical expenditure was $51.84 billion (£39.6 billion) in 2021. Furthermore, spending on preventive care was $45.93 billion (£35.1 billion) in 2021, more than doubling from the previous year. Therefore, growing expenditure for the healthcare sector is driving the growth of the small animal imaging (in-vivo) market.

Competitive Landscape -
Major companies operating in the small animal imaging (in-vivo) market include Bruker Corporation, PerkinElmer Inc., Miltenyi Biotec GmbH, Aspect Imaging Ltd., Mediso Ltd., Siemens AG, Life Technologies Corporation, Promega Corporation, McKesson Corporation, Integra LifeSciences Holdings Corporation, Smith & Nephew plc, B. Braun Melsungen AG, Paul Hartmann AG, Nitto Denko Corporation, Beiersdorf Aktiengesellschaft, NICHIBAN Co. Ltd., Coloplast A/S, Scapa Group plc, Milliken & Company, Winner Medical Group Inc., Hollister Incorporated, Avcor Health Care Products Inc., Advancis Medical LLC, The ASO Group, Dynarex Corporation, Jiangxi 3L Medical Products Group Co. Ltd., Berthold Technologies GmbH and Co. KG, Spectral Instruments Imaging LLC, Agilent Technologies Inc., Bioscan Inc., Gamma Medica-Ideas Inc., Genovis AB, LI-COR Biosciences, Scanco Medical AG, TriFoil Imaging Inc.

Technology Advancements Drive Growth In The Small Animal Imaging (In-Vivo) Market
Technological advancement is a key trend gaining popularity in the small animal imaging (in-vivo) market. Major companies operating in the small animal imaging (in vivo) market are focused on technological advancement to strengthen their position. For instance, in April 2022, PerkinElmer, Inc., a US-based company engaged in business areas such as diagnostics, life science research, and imaging, launched the Vega imaging system, an automated advanced technology ultrasound platform. Automated technology involves the use of two automated transducers, resulting in easy-to-use technology and generating more consistent results to visualize the pathophysiology of the disease.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/small-animal-imaging-in-vivo-global-market-report

Key Segments -
The small animal imaging (in-vivo) market covered in this report is segmented -
1) By Component: Micro-MRI, Optical Imaging, Nuclear Imaging, Other Components
2) By Application: Monitoring Treatment Response, Bio Distribution, Determining Drug or Target Engagement, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Epigenetics
3) By End User: Veterinary Clinics, Veterinary Hospitals, Veterinary Institutes and Research Centers

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.